DrugPatentWatch Database Preview
Profile for Japan Patent: 5216328
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Japan Patent: 5216328
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 4, 2026 | Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate |
Start Trial | Oct 4, 2026 | Antares Pharma Inc | OTREXUP | methotrexate |
Start Trial | Oct 4, 2026 | Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate |
Start Trial | Jan 24, 2026 | Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate |
Start Trial | Jan 24, 2026 | Antares Pharma Inc | OTREXUP | methotrexate |
Start Trial | Jan 24, 2026 | Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |